share_log

Roth MKM Reiterates Buy on BioRestorative Therapies, Maintains $15 Price Target

Benzinga ·  Aug 14, 2023 09:51

Roth MKM analyst Jonathan Aschoff reiterates BioRestorative Therapies (NASDAQ:BRTX) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment